// App-Quantinova.ai

: Impact of a Pharmacist Driven Anti-Xa Level Monitoring Protocol on Therapeutic Drug Monitoring Practice Patterns

Researchers

Presenter

  • Muhammad Effendi

Principal Investigators

  • Martha Stutsky

  • Caleigh A. Curran

  • Kent A. Owusu

  • Alfred Ian Lee

Medical Centers

  • Yale New Haven Hospital, New Haven, CT

  • Department of Medical Oncology, Yale University School of Medicine, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved